ReviewInterindividual Variability in Nicotine Metabolism: C-Oxidation and Glucuronidation
References (57)
- et al.
Poor metabolisers of nicotine and CYP2D6 polymorphism
Lancet
(1994) - et al.
CYP2A6*6, a novel polymorphism in cytochrome P450 2A6, has a single amino acid substitution (R128Q) that inactivates enzymatic activity
J. Biol. Chem.
(2001) - et al.
An in vivo pilot study characterizing the new CYP2A6*7, *8, and *10 alleles
Biochem. Biophys. Res. Commun.
(2002) - et al.
Characterization and PCR-based detection of CYP2A6 gene deletion found at a high frequency in a Chinese population
FEBS Lett.
(1999) - et al.
Identification and characterization of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism
FEBS Lett.
(1999) - et al.
A novel single nucleotide polymorphism altering stability and activity of CYP2A6
Biochem. Biophys. Res. Commun.
(2001) - et al.
Identification of a single nucleotide polymorphism in the TATA box of the CYP2A6 gene: impairment of its promoter activity
Biochem. Biophys. Res. Commun.
(2001) - et al.
Metabolic profile of nicotine in subjects whose CYP2A6 gene is deleted
Eur. J. Pharm. Sci.
(2004) Nicotine metabolism, human drug metabolism polymorphisms, and smoking behavior
Toxicology
(2003)- et al.
Genetic variations and haplotypes of UGT1A4 in a Japanese population
Drug Metab. Pharmacokinet.
(2005)
The effect of valproic acid on drug and steroid glucuronidation by expressed human UDP-glucuronosyltransferases
Biochem. Pharmacol.
(2003)
Cigarette smoking and lung disease
Am. J. Med. Sci.
(1986)
Drug therapy
Pharmacologic aspects of cigarette smoking and nicotine addiction. N. Engl. J. Med.
(1988)
Cigarette smoking, nicotine addiction, and its pharmacologic treatment
Arch. Intern. Med.
(1993)
Cigarette smoking: A dependence on high-nicotine boli
Drug Metab. Rev.
(1978)
Role of human cytochrome P4502A6 in C-oxidation of nicotine
Drug Metab. Dispos.
(1996)
Characterization of CYP2A6 involved in 3'-hydroxylation of cotinine in human liver microsomes
J. Pharmacol. Exp. Ther.
(1996)
Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine
J. Pharmacol. Exp. Ther.
(1994)
Evidence for urinary excretion of glucuronide conjugates of nicotine, cotinine, and trans- 3'-hydroxycotinine in smokers
Drug Metab. Dispos.
(1992)
Metabolism of nicotine by human liver microsomes: stereoselective formation of trans-nicotine N' -oxide
Chem. Res. Toxicol.
(1992)
Characterization of multiple products of cytochrome P450 2A6-catalyzed cotinine metabolism
Chem. Res. Toxicol.
(1999)
Deficient C-oxidation of nicotine
Clin. Pharmacol. Ther.
(1995)
Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking
Mol. Pharmacol.
(2000)
Pharmacokinetics of nicotine, cotinine, and 3?-hydroxycotinine in cigarette smokers
Klin. Wochenschr.
(1988)
Deficient cotinine formation from nicotine is attributed to the whole deletion of the CYP2A6 gene in humans
Clin. Pharmacol. Ther
(2000)
Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans
Clin. Pharmacol. Ther.
(2001)
Nicotine metabolism and CYP2A6 allele frequencies in Koreans
Pharmacogenetics
(2001)
A new CYP2A6 gene deletion responsible for the in vivo polymorphic metabolism of (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride in humans
J. Pharmacol. Exp. Ther.
(1999)
Cited by (0)
Copyright Ā© 2005 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.